Pharma General
Pharma General
Pharma General
Bioavailability:
• Rate and extent of drug absorption
• Depends upon – Route of administration
• Maximum bioavailability – intravenous route (100%)
Purpose:
• Reduce degradation of drugs in acidic pH of stomach
• Allow drugs to pass unhindered into the small intestine
• Reduce gastric irritation of drugs
Examples:
• Erythromycin esteolate
• PPIs
A. Anticholinergics
B. Beta agonists
R. Ribavirin
I. Insulin (Affrezza)
T. Tobramycin
Z. Zanamivir
P. Prostacyclin analogue – Iloprost
L. Loxapine
A. Amyl nitrite
N. Nicotine
S. Steroids
C. Colistin
A. Anaesthetics (inhaled)
N. Nitric oxide
Advantages:
• Reduces local irritation due to the medication
• Less painful than traditional intramuscular injection
Used for –
• Iron injections
• Depot antipsychotics
Drug distribution
1. Carbamazepine 5. Phenobarbitone
2. Lithium 6. Salicylates
3. Ethylene glycol 7. Theophylline
4. Methanol 8. Valproate
1. Sulfonamides displace bilirubin from albumin binding sites – increased risk of kernicterus
2. Loop diuretics and valproate displace warfarin from plasma protein binding sites –
increased risk of bleeding due to warfarin
Drug metabolism
Drug excretion
PK PARAMETER SIGNIFICANCE
1 Bioavailability Rate and extent of drug absorption
2 Volume of distribution Extent of tissue penetration of drug
3 Half life Rate of drug elimination >
Duration of drug action
4 Clearance Ability of the body to excrete the drug
Dose-response curves
• ED50 / LD 50 ratio
• Best indicator of – drug safety
• Drug is considered safe if – TI > 2
• If TI < 2 – Unsafe (Narrow TI)
• Digoxin
• Antiarrhythmics
• Theophylline
• Lithium
• Aminoglycosides
• Anti-epileptics
• TCAs
• Methotrexate
• Calcineurin inhibitors
Orphan drugs:
• Drugs for rare diseases or for more common diseases (endemic in a resource poor setting)
• Cost of development and marketing cannot be recovered by sales
• No interest shown by pharma companies
• Incentives provided by Govt – tax benefits, discount for filing applications, market
exclusivity, etc.
Schedule Description
H Drugs to be sold only on the prescription by a RMP
H1 Antibiotics
X Narcotics and Psychotropic drugs
Records to be maintained by pharmacist when sold
Advantages Disadvantages
1. Convenience of drug 1. Patient may not actually need all the drugs in
administration the combination – unnecessary exposure and
2. Better patient compliance possible adverse effects at additional cost
3. Certain combinations may be 2. Individualization of drug doses and dose
synergistic (e.g.: adjustment not possible
Sulfamethoxazole + 3. Time course of action of active ingredients may
Trimethoprim, Levodopa + be different – administering at same intervals
Carbidopa) may be inappropriate
4. Adverse effect of one active 4. Altered renal or hepatic function may affect
ingredient may be countered the pharmacokinetics of individual components
by the other (e.g.: differently
Spironolactone can prevent 5. Adverse effect may not be ascribed to one
hypokalemia due to thiazides) particular component
5. Better for conditions where 6. If adverse effect to any one component occurs,
combination therapy is whole FDC may have to be discontinued
required. E.g.: Tuberculosis, HIV- 7. Contraindication to one of the active
AIDS, etc. ingredients contraindicates the whole FDC
❑ ❑ ❑